Susie M Liu, MD
Gastroenterology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Liu’s office at (650) 324-4400 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$94,886
Medicare paid this office $94,886 for 344 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 125 | $17,546 | $107 |
| New patient visit (45+ min) | 117 | $14,820 | $127 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 57 | $11,114 | $195 |
| Long return visit (40+ min) | 65 | $10,768 | $152 |
| Removal of large bowel tissue using a flexible endoscope | 33 | $8,994 | $273 |
See all 13 services
| Return visit (30+ min) | 125 | $17,546 | $107 |
| New patient visit (45+ min) | 117 | $14,820 | $127 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 57 | $11,114 | $195 |
| Long return visit (40+ min) | 65 | $10,768 | $152 |
| Removal of large bowel tissue using a flexible endoscope | 33 | $8,994 | $273 |
| New patient visit (60+ min) | 41 | $7,323 | $179 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 73 | $5,383 | $74 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 30 | $5,050 | $168 |
| Short return visit (20+ min) | 50 | $4,591 | $77 |
| Biopsy of large bowel using a flexible endoscope | 43 | $4,185 | $97 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,139 | $178 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,716 | $156 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 89 | $364 | $4 |
Procedures Medicare counted
| Colonoscopy | 212 | More than 94% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 124 | More than 81% of doctors who do this |
Who their Medicare patients are
344 Original Medicare patients in 2024. Average age 75 · Under 65 0% · 85 and older 7% · Women 67% · Health risk score 0.72. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 61% · Coronary heart disease 22% · Diabetes 17% · Cancer 17% · Atrial fibrillation 12% · Chronic kidney disease 10% · Depression 10% · COPD 6% · Stroke 5% · Heart failure 4%.
The office billed $433,425, Medicare allowed $125,817 and paid $94,886; for 817 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 344 | 817 | 75 | 0.72 | $433,425 | $94,886 |
| 2023 | 307 | 751 | 74 | 0.72 | $427,989 | $88,642 |
| 2022 | 295 | 736 | 75 | 0.68 | $361,052 | $85,708 |
| 2021 | 312 | 834 | 74 | 0.86 | $498,564 | $90,466 |
| 2020 | 268 | 739 | 74 | 0.72 | $426,660 | $73,091 |
| 2019 | 281 | 728 | 74 | 0.76 | $475,710 | $71,575 |
| 2018 | 273 | 927 | 74 | 0.78 | $479,520 | $71,922 |
| 2017 | 282 | 949 | 74 | 0.81 | $536,455 | $71,487 |
| 2016 | 280 | 534 | 73 | 0.74 | $434,327 | $66,891 |
| 2015 | 287 | 553 | 73 | 0.73 | $454,825 | $77,575 |
| 2014 | 295 | 608 | 73 | 0.65 | $495,314 | $83,201 |
| 2013 | 285 | 599 | 73 | 0.75 | $432,207 | $85,418 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| New patient visit (45+ min) | 115 | $14,295 | $124 |
| Return visit (30+ min) | 90 | $12,105 | $107 |
| Long return visit (40+ min) | 67 | $11,269 | $150 |
| New patient visit (60+ min) | 55 | $10,003 | $182 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 44 | $8,615 | $196 |
| Removal of large bowel tissue using a flexible endoscope | 29 | $8,352 | $278 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 40 | $7,362 | $180 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 70 | $6,214 | $88 |
| Biopsy of large bowel using a flexible endoscope | 51 | $4,466 | $88 |
| Short return visit (20+ min) | 32 | $2,808 | $74 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 95 | $418 | $4 |
2022: 14 services
| New patient visit (60+ min) | 64 | $12,349 | $193 |
| Return visit (30+ min) | 88 | $11,427 | $109 |
| Long return visit (40+ min) | 63 | $10,477 | $164 |
| New patient visit (45+ min) | 71 | $9,212 | $130 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 37 | $7,224 | $195 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 84 | $6,823 | $78 |
| Removal of large bowel tissue using a flexible endoscope | 24 | $6,772 | $282 |
| Biopsy of large bowel using a flexible endoscope | 62 | $6,217 | $100 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 30 | $5,984 | $199 |
| Short return visit (20+ min) | 34 | $3,248 | $83 |
| Diagnostic exam of large bowel using a flexible endoscope | 21 | $3,235 | $154 |
| New patient visit (30+ min) | 16 | $851 | $53 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 93 | $405 | $4 |
| Injection beneath lining of large bowel using a flexible endoscope | 12 | $170 | $14 |
2021: 13 services
| Return visit (30+ min) | 91 | $13,805 | $124 |
| Long return visit (40+ min) | 73 | $13,206 | $161 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 54 | $12,147 | $225 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 50 | $10,789 | $216 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 93 | $7,953 | $85 |
| New patient visit (45+ min) | 59 | $7,853 | $133 |
| New patient visit (60+ min) | 37 | $7,571 | $205 |
| Biopsy of large bowel using a flexible endoscope | 62 | $6,847 | $110 |
| Short return visit (20+ min) | 31 | $3,326 | $90 |
| New patient visit (30+ min) | 13 | $912 | $70 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 140 | $650 | $5 |
| Telephone medical discussion with physician, 5-10 minutes | 19 | $616 | $31 |
| Injection beneath lining of large bowel using a flexible endoscope | 38 | $563 | $15 |
2020: 12 services
| Long return visit (40+ min) | 89 | $13,226 | $124 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 52 | $11,098 | $213 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 48 | $10,356 | $216 |
| Return visit (30+ min) | 70 | $9,120 | $94 |
| New patient visit (45+ min) | 50 | $6,889 | $138 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 60 | $5,397 | $87 |
| New patient visit (60+ min) | 27 | $4,527 | $168 |
| Biopsy of large bowel using a flexible endoscope | 40 | $3,808 | $95 |
| Short return visit (20+ min) | 33 | $2,756 | $71 |
| Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | 18 | $1,045 | $58 |
| Injection beneath lining of large bowel using a flexible endoscope | 42 | $628 | $15 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 124 | $599 | $5 |
2019: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 58 | $12,574 | $217 |
| Long return visit (40+ min) | 75 | $12,057 | $123 |
| New patient visit (60+ min) | 58 | $9,908 | $171 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 44 | $9,368 | $213 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 72 | $6,594 | $87 |
| Return visit (30+ min) | 43 | $5,332 | $94 |
| Biopsy of large bowel using a flexible endoscope | 40 | $3,689 | $92 |
| New patient visit (45+ min) | 24 | $3,250 | $135 |
| Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | 23 | $2,185 | $95 |
| Diagnostic exam of large bowel using a flexible endoscope | 16 | $2,182 | $136 |
| Injection beneath lining of large bowel using a flexible endoscope | 55 | $832 | $15 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 157 | $720 | $4 |
2018: 11 services
| Colorectal cancer screening; colonoscopy on individual at high risk | 60 | $12,752 | $213 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 53 | $11,698 | $221 |
| Long return visit (40+ min) | 70 | $10,713 | $119 |
| New patient visit (60+ min) | 56 | $9,478 | $169 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 71 | $6,228 | $87 |
| Biopsy of large bowel using a flexible endoscope | 63 | $5,734 | $91 |
| Return visit (30+ min) | 39 | $4,459 | $89 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 139 | $2,222 | $11 |
| Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | 18 | $903 | $50 |
| Injection beneath lining of large bowel using a flexible endoscope | 45 | $863 | $19 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 175 | $821 | $5 |
2017: 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 64 | $13,438 | $210 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 62 | $12,631 | $204 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 82 | $7,244 | $87 |
| Long return visit (40+ min) | 51 | $7,066 | $118 |
| New patient visit (60+ min) | 41 | $6,587 | $161 |
| Return visit (30+ min) | 52 | $5,886 | $87 |
| Biopsy of large bowel using a flexible endoscope | 66 | $5,443 | $82 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 141 | $2,013 | $11 |
| Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | 18 | $1,372 | $76 |
| Injection beneath lining of large bowel using a flexible endoscope | 66 | $1,130 | $17 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 173 | $785 | $4 |
2016: 9 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 57 | $13,199 | $228 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 56 | $11,929 | $213 |
| Biopsy of large bowel using a flexible endoscope | 82 | $8,190 | $100 |
| Long return visit (40+ min) | 56 | $7,522 | $130 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 66 | $6,283 | $92 |
| Return visit (30+ min) | 50 | $5,229 | $95 |
| New patient visit (60+ min) | 26 | $4,697 | $181 |
| Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | 34 | $2,423 | $69 |
| Injection beneath lining of large bowel using a flexible endoscope | 51 | $965 | $19 |
2015: 9 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 62 | $16,560 | $263 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 48 | $10,535 | $219 |
| Biopsy of large bowel using a flexible endoscope | 64 | $8,333 | $128 |
| Long return visit (40+ min) | 55 | $7,895 | $123 |
| Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | 53 | $7,497 | $139 |
| Return visit (30+ min) | 62 | $6,320 | $90 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 63 | $6,254 | $99 |
| New patient visit (60+ min) | 26 | $4,761 | $183 |
| Injection beneath lining of large bowel using a flexible endoscope | 61 | $3,181 | $51 |
2014: 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 76 | $20,668 | $265 |
| Biopsy of large bowel using a flexible endoscope | 84 | $10,609 | $126 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 38 | $9,040 | $232 |
| Return visit (30+ min) | 69 | $7,588 | $93 |
| Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | 63 | $7,295 | $112 |
| New patient visit (60+ min) | 37 | $6,407 | $173 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 56 | $5,672 | $100 |
| Long return visit (40+ min) | 34 | $4,855 | $124 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,832 | $236 |
| Short return visit (20+ min) | 27 | $1,869 | $60 |
| Injection beneath lining of large bowel using a flexible endoscope | 55 | $1,431 | $26 |
2013: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 69 | $18,519 | $265 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 40 | $9,674 | $242 |
| Long return visit (40+ min) | 63 | $9,512 | $129 |
| Return visit (30+ min) | 78 | $9,002 | $92 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 72 | $8,518 | $114 |
| Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | 61 | $8,474 | $137 |
| New patient visit (60+ min) | 41 | $7,252 | $177 |
| Biopsy of large bowel using a flexible endoscope | 62 | $7,248 | $117 |
| Short return visit (20+ min) | 20 | $1,565 | $68 |
| Injection beneath lining of large bowel using a flexible endoscope | 24 | $630 | $26 |
Drugs they prescribed that Part D paid
$53,362
Pharmacies billed $53,362 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 488) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
430 generic and 58 brand-name prescriptions · $53,362 in drug cost · 20 antibiotic prescriptions to 18 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Linzess | 24 | $22,780 | $949 |
| Dexlansoprazole Dr | 11 | $3,751 | $341 |
| Mesalamine | 21 | $3,699 | $176 |
| Pantoprazole | 147 | $2,437 | $17 |
| Peg3350-Sod Sul-Nacl-Kcl-Asb-C | 23 | $1,737 | $76 |
See all 11 drugs
| Linzess | 24 | $22,780 | $949 |
| Dexlansoprazole Dr | 11 | $3,751 | $341 |
| Mesalamine | 21 | $3,699 | $176 |
| Pantoprazole | 147 | $2,437 | $17 |
| Peg3350-Sod Sul-Nacl-Kcl-Asb-C | 23 | $1,737 | $76 |
| Lansoprazole | 15 | $1,689 | $113 |
| Lubiprostone | 13 | $1,506 | $116 |
| Omeprazole | 71 | $1,431 | $20 |
| Esomeprazole Magnesium | 24 | $1,043 | $43 |
| Famotidine | 70 | $705 | $10 |
| Hydrocortisone | 12 | $171 | $14 |
Year by year
| 2024 | 488 | 169 | 0% (0) | 12% | $53,362 |
| 2023 | 518 | 180 | 0% (0) | 15% | $59,099 |
| 2022 | 624 | 229 | 0% (0) | 28% | $77,457 |
| 2021 | 661 | 240 | 0% (0) | 27% | $71,866 |
| 2020 | 531 | 185 | 0% (0) | 28% | $70,093 |
| 2019 | 553 | 199 | 0% (0) | 29% | $62,148 |
| 2018 | 505 | 201 | 0% (0) | 34% | $55,923 |
| 2017 | 489 | 186 | 0% (0) | 33% | $54,008 |
| 2016 | 497 | 177 | 0% (0) | 36% | $67,438 |
| 2015 | 543 | 186 | 0% (0) | 45% | $75,380 |
| 2014 | 540 | 164 | 0% (0) | 45% | $91,307 |
| 2013 | 593 | 158 | None | None | $95,410 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Linzess | 23 | $13,975 | $608 |
| Dexlansoprazole Dr | 24 | $11,342 | $473 |
| Mesalamine | 18 | $8,818 | $490 |
| Lubiprostone | 19 | $7,211 | $380 |
| Pantoprazole | 173 | $3,847 | $22 |
| Sod Sulf-Potass Sulf-Mag Sulf | 23 | $1,832 | $80 |
| Esomeprazole Magnesium | 27 | $1,287 | $48 |
| Famotidine | 69 | $1,247 | $18 |
| Omeprazole | 63 | $1,180 | $19 |
| Peg3350-Sod Sul-Nacl-Kcl-Asb-C | 11 | $1,011 | $92 |
2022: 12 drugs
| Linzess | 32 | $17,771 | $555 |
| Dexlansoprazole Dr | 18 | $8,609 | $478 |
| Dexilant | 19 | $8,240 | $434 |
| Mesalamine | 12 | $7,691 | $641 |
| Suprep | 62 | $7,202 | $116 |
| Lubiprostone | 14 | $6,096 | $435 |
| Pantoprazole | 209 | $4,309 | $21 |
| Esomeprazole Magnesium | 29 | $2,291 | $79 |
| Omeprazole | 60 | $2,063 | $34 |
| Famotidine | 69 | $978 | $14 |
| Sod Sulf-Potass Sulf-Mag Sulf | 12 | $966 | $81 |
| Peg 3350-Electrolyte | 13 | $242 | $19 |
2021: 9 drugs
| Linzess | 41 | $21,628 | $528 |
| Dexilant | 31 | $9,782 | $316 |
| Suprep | 80 | $8,859 | $111 |
| Mesalamine | 13 | $8,676 | $667 |
| Pantoprazole | 226 | $5,212 | $23 |
| Omeprazole | 88 | $2,504 | $28 |
| Esomeprazole Magnesium | 20 | $2,257 | $113 |
| Famotidine | 74 | $1,339 | $18 |
| Peg 3350-Electrolyte | 11 | $147 | $13 |
2020: 8 drugs
| Dexilant | 42 | $14,705 | $350 |
| Mesalamine | 22 | $12,613 | $573 |
| Suprep | 67 | $7,057 | $105 |
| Esomeprazole Magnesium | 28 | $3,773 | $135 |
| Pantoprazole | 182 | $3,733 | $21 |
| Omeprazole | 78 | $1,827 | $23 |
| Sucralfate | 11 | $862 | $78 |
| Famotidine | 34 | $552 | $16 |
2019: 7 drugs
| Mesalamine | 23 | $9,821 | $427 |
| Dexilant | 22 | $9,741 | $443 |
| Suprep | 91 | $8,945 | $98 |
| Pantoprazole | 220 | $4,972 | $23 |
| Esomeprazole Magnesium | 27 | $1,819 | $67 |
| Omeprazole | 66 | $1,451 | $22 |
| Famotidine | 15 | $289 | $19 |
2018: 8 drugs
| Dexilant | 33 | $13,647 | $414 |
| Suprep | 97 | $9,078 | $94 |
| Nexium | 11 | $5,847 | $532 |
| Esomeprazole Magnesium | 25 | $3,325 | $133 |
| Pantoprazole | 166 | $3,096 | $19 |
| Omeprazole | 77 | $1,903 | $25 |
| Famotidine | 31 | $594 | $19 |
| Sulfasalazine | 12 | $583 | $49 |
2017: 8 drugs
| Suprep | 96 | $8,419 | $88 |
| Dexilant | 13 | $8,376 | $644 |
| Nexium | 15 | $7,508 | $501 |
| Esomeprazole Magnesium | 29 | $5,621 | $194 |
| Pantoprazole | 140 | $2,496 | $18 |
| Omeprazole | 79 | $2,161 | $27 |
| Sulfasalazine | 13 | $633 | $49 |
| Famotidine | 29 | $329 | $11 |
2016: 8 drugs
| Nexium | 32 | $17,621 | $551 |
| Dexilant | 27 | $11,998 | $444 |
| Suprep | 88 | $7,261 | $83 |
| Esomeprazole Magnesium | 11 | $2,863 | $260 |
| Omeprazole | 104 | $2,154 | $21 |
| Pantoprazole | 129 | $2,069 | $16 |
| Famotidine | 18 | $316 | $18 |
| Warfarin | 16 | $144 | $9 |
2015: 7 drugs
| Nexium | 44 | $25,337 | $576 |
| Dexilant | 75 | $21,483 | $286 |
| Suprep | 88 | $7,095 | $81 |
| Pantoprazole | 132 | $2,640 | $20 |
| Omeprazole | 101 | $2,353 | $23 |
| Rabeprazole | 11 | $431 | $39 |
| Lansoprazole | 11 | $341 | $31 |
2014: 7 drugs
| Nexium | 75 | $43,485 | $580 |
| Dexilant | 52 | $14,521 | $279 |
| Suprep | 73 | $5,709 | $78 |
| Omeprazole | 112 | $2,730 | $24 |
| Pantoprazole | 139 | $2,552 | $18 |
| Rabeprazole | 13 | $563 | $43 |
| Lansoprazole | 15 | $477 | $32 |
2013: 8 drugs
| Nexium | 73 | $37,245 | $510 |
| Dexilant | 52 | $13,141 | $253 |
| Aciphex | 18 | $9,284 | $516 |
| Omeprazole | 148 | $5,103 | $34 |
| Suprep | 67 | $4,876 | $73 |
| Pantoprazole | 143 | $2,730 | $19 |
| Flovent Hfa | 11 | $1,832 | $167 |
| Lansoprazole | 20 | $1,572 | $79 |
Money from drug and device companies
$122 in 2025
| 2025 | 1 | 1 | None | $122 |
| 2024 | 1 | 1 | None | $12 |
| 2023 | 1 | 1 | None | $18 |
| 2020 | 2 | 2 | None | $247 |
| 2019 | 4 | 5 | None | $541 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Lilly USA | Omvoh | $122 | 1 payment
|
See the published payment
| Lilly USA | Meals · 2025-09-08 | Omvoh | $122 |
See earlier years (2024, 2023, 2020, 2019)
2024: $12
| Micro-tech Endoscopy USA | Eyemx | $12 | 1 payment
|
2023: $18
| Abbvie | Linzess | $18 | 1 payment
|
2020: $247
| Allergan | None | $125 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Motegrity | $122 | 1 payment
|
2019: $541
| Medtronic USA | Kyphon Balloon Kyphoplasty | $167 | 2 payments
|
| Teva Pharmaceuticals USA | Ajovy | $125 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $125 | 1 payment
|
| AbbVie | None | $124 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1598775223
- Licence
- CA G067248
- Trained
- University of Missouri, Kansas City, School of Medicine, 1988
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 900 Welch Road, Suite 202, Palo Alto, CA, 94304
- NPI first listed
- 2006-08-08
- NPI last updated
- 2015-02-21
This is when the NPI record was last certified, not a medical board exam.